Stakeholders’ Involvement in Health Technology Assessment in Kazakhstan, Poland and Bulgaria

References

• O’Rourke B, Oortwijn W, Schuller T.; International Joint Task Group. The new definition of health technology assessment: a milestone in international collaboration. Int J Technol Assess Health Care. 2020;36(3):187–190. doi:10.1017/S0266462320000215
   PubMed Web of Science ®Google Scholar
• van der Wilt GJ, Bloemen B, Grin J, et al. Integrating empirical analysis and normative inquiry in health technology assessment: the values in doing assessments of health technologies approach. Int J Technol Assess Health Care. 2022;38(1):e52. doi:10.1017/S0266462321001768
   PubMedGoogle Scholar
• Baltussen R, Paul Maria Jansen M, Bijlmakers L, et al. Value assessment frameworks for HTA agencies: the organization of evidence-informed deliberative processes. Value Health. 2017;20(2):256–260. doi:10.1016/j.jval.2016.11.019
   PubMed Web of Science ®Google Scholar
• Yazdizadeh B, Shahmoradi S, Majdzadeh R, et al. Stakeholder involvement in Health technology assessment at National level: a study from Iran. Int J Technol Assess Health Care. 2016;32(3):181–189. doi:10.1017/S0266462316000167
   PubMed Web of Science ®Google Scholar
• Kosherbayeva L, Hailey D, Kurakbaev K, et al. A process of prioritizing topics for health technology assessment in Kazakhstan. Int J Technol Assess Health Care. 2016;32(3):147–151. doi:10.1017/S0266462316000222
   PubMed Web of Science ®Google Scholar
• Decree of the minister of health on the agency for health technology assessment in Poland [Zarządzenie Ministra Zdrowia zmieniające zarządzenie w sprawie Agencji Oceny Technologii Medycznych]. Available from: http://www.aotm.gov.pl/pliki/onas/zarzadzenie_10_09_2008.pdf. Accessed December 18, 2023.
   Google Scholar
• Ordinance on the terms, rules and procedure for regulation and registration of prices for medicinal products, Art. 1, item 8 and Chapter Six (SG, issue 26 of 2019, in force from 01.04.2019). Available from: https://www.ncpr.bg/en/health-technology-assessment/regulations.html). Accessed December 18, 2023.
   Google Scholar
• On approval of the rules for assessing health technologies and their application order of the minister of health of the Republic of Kazakhstan dated November 30, 2020 No. KR DSM-215/2020. Registered with the Ministry of Justice of the Republic of Kazakhstan on December 2, 2020. Russian and Kazakh. https://adilet.zan.kz/rus/docs/V2000021705. Accessed May 14, 2024.
   Google Scholar
• Oortwijn W, Surgey G, Novakovic T, Baltussen R, Kosherbayeva L. The use of evidence-informed deliberative processes for health benefit package design in Kazakhstan. Int J Environ Res Public Health. 2022;19(18):11412. doi:10.3390/ijerph191811412
   PubMed Web of Science ®Google Scholar
• Medicinal products in human medicine, Art. 259, para 1, item 6 of (SG, issue 102 of 2018, in force from 01.01.2019); Bulgaria regulatory document.
   Google Scholar
• Pichon-Riviere A, Soto N, Augustovski F, Sampietro-Colom L. Stakeholder involvement in the health technology assessment process in Latin America. Int J Technol Assess Health Care. 2018;34(3):248–253. doi:10.1017/S0266462318000302
   PubMed Web of Science ®Google Scholar
• Cavazza M, Jommi C. Stakeholders involvement by HTA Organisations: why is so different? Health Policy. 2012;105(2–3):236–245. doi:10.1016/j.healthpol.2012.01.012
   PubMed Web of Science ®Google Scholar
• Concannon TW, Meissner P, Grunbaum JA, et al. A new taxonomy for stakeholder engagement in patient centered outcomes research. J Gen Intern Med. 2012;27(8):985–991. doi:10.1007/s11606-012-2037-1
   PubMed Web of Science ®Google Scholar
• Street J, Stafinski T, Lopes E, Menon D. Defining the role of the public in Health Technology Assessment (HTA) and HTA-informed decision-making processes. Int J Technol Assess Health Care. 2020;36(2):87–95. doi:10.1017/S0266462320000094
   PubMed Web of Science ®Google Scholar
• Patient Involvement in Health Technology Assessment in Europe. Results of the European Patients’ forum Survey. Available from: https://www.eu-patient.eu/globalassets/projects/hta/hta-epf-final-report2013.pdf. Accessed May 14, 2024.
   Google Scholar
• Goetghebeur M, Cellier M. Deliberative processes by health technology assessment agencies: a reflection on legitimacy, values and patient and public involvement comment on “use of evidence-informed deliberative processes by health technology assessment agencies around the globe”. Int J Health Policy Manag. 2021;10(4):228–231. doi:10.34172/ijhpm.2020.46
   PubMed Web of Science ®Google Scholar
• Syrett K. Expanded HTA, Legitimacy and Independence Comment on Expanded HTA: enhancing Fairness and Legitimacy. Int J Health Policy Manage. 2016;5(9):565–567. doi:10.15171/ijhpm.2016.75
   PubMed Web of Science ®Google Scholar
• Sagan A, Kowalska-Bobko I, Badora-Musiał K, Gałązka-Sobotka M. A reform proposal from 2019 aims to improve coordination of health services in Poland by strengthening the role of the counties. Health Policy. 2022;126(9):837–843. doi:10.1016/j.healthpol.2022.06.006
   PubMed Web of Science ®Google Scholar
• Sowada C, Sagan A, Kowalska-Bobko I, et al. Poland: health system review. Health Syst Transit. 2019;21(1):1–235.
   PubMedGoogle Scholar
• Scott AM, Wale JL; & On behalf of the HTAi Patient and Citizen Involvement in HTA Interest Group, Patient Involvement and Education Working Group. Patient advocate perspectives on involvement in HTA: an international snapshot. Res Involv Engagem. 2017;3(2). doi:10.1186/s40900-016-0052-9
   Google Scholar
• Menon D, Stafinski T. Role of patient and public participation in health technology assessment and coverage decisions. Expert Rev Pharmacoecon Outcomes Res. 2011;11(1):75–89. doi:10.1586/erp.10.82
   PubMed Web of Science ®Google Scholar
• Gagnon MP, Desmartis M, Lepage-Savary D, et al. Introducing patients’ and the public’s perspectives to health technology assessment: a systematic review of international experiences. Int J Technol Assess Health Care. 2011;27(1):31–42. doi:10.1017/S0266462310001315
   PubMed Web of Science ®Google Scholar
• Regulation (EU) 2021/2282 of the European parliament and of the council of 15 December 2021 on health technology assessment and amending directive; 2011. Available from: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32021R2282. Accessed May 14, 2024.
   Google Scholar